Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer
Zhengjia Lu, Jiao Yang, Yang Feng, Jia Ming
Springer Nature ·
2025-07-01
· DOI 10.1186/s12885-025-14451-y
The publisher did not provide an abstract — full text is available via the link below.
Zhengjia Lu, Jiao Yang, Yang Feng, Jia Ming. Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14451-y. – URL: https://doi.org/10.1186/s12885-025-14451-y
Zhengjia Lu, Jiao Yang, Yang Feng, & Jia Ming (2025). Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer. BMC Cancer. https://doi.org/10.1186/s12885-025-14451-y
Zhengjia Lu, et al. “Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.” BMC Cancer, 2025. doi:10.1186/s12885-025-14451-y.
@article{Lu2025,
title = {Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer},
author = {Lu, Zhengjia and Yang, Jiao and Feng, Yang and Ming, Jia},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14451-y},
url = {https://doi.org/10.1186/s12885-025-14451-y}
}